Molecular diagnosis of sepsis

Expert Opinion on Medical Diagnostics

Volumn 6, Issue 3, 2012, Pages 209-219

  Kotsaki, Antigone ^a   Giamarellos Bourboulis, Evangelos J ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Diagnosis; Pathogens; Sepsis; SeptiFast; Transcriptome

Indexed keywords

PEPTIDE NUCLEIC ACID; TRANSCRIPTOME;

ANTIBIOTIC SENSITIVITY; BLOOD; BLOOD CULTURE; BLOOD EXAMINATION; CLINICAL PRACTICE; EARLY DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; HUMAN; IMMUNE RESPONSE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DIAGNOSIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW; SEPSIS;

EID: 84860251265     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2012.667799     Document Type: Review

References (78)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10
2. Giamarellos-Bourboulis EJ. What is the pathophysiology of the septic host upon admission? Int J Antimicrob Agents 2010;36(Suppl 2):S2-5
3. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96
4. Peters RP, van Agtmael MA, Danner SA, et al. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004;4:751-60
5. Beekmann SE, Diekema DJ, Chapin KC, Doern GV. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol 2003;41:3119-25
6. Thomas LC, Gidding HF, Ginn AN, et al. Development of a real-time Staphylococcus aureus and MRSA (SAM- ) PCR for routine blood culture. J Microbiol Methods 2007;68:296-302
7. Eigner U, Weizenegger M, Fahr AM, Witte W. Evaluation of a rapid direct assay for identification of bacteria and the mecA and van genes from positive-testing blood cultures. J Clin Microbiol 2005;43:5256-62
8. Waterer G, Rello J. Why should we measure bacterial load when treating community-acquired pneumonia? Curr Opin Infect Dis 2011;23:137-41
9. Turenne CY, Witwicki E, Hoban DJ, et al. Rapid identification of bacteria from positive blood cultures by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene. J Clin Microbiol 2000;8:513-20
10. Jordan JA, Jones-Laughner J, Durso MB. Utility of pyrosequencing in identifying bacteria directly from positive blood culture bottles. J Clin Microbiol 2009;47:368-72
11. Louie L, Goodfellow J, Mathieu P, et al. Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J Clin Microbiol 2002;40:2786-90
12. Wellinghausen N, Wirths B, Essig A, Wassill L. The Hyplex BloodScreen multiplex PCR-enzyme-linked immunosorbent assay evaluation of system for direct identification of gram-positive cocci and gram-negative bacilli from positive blood cultures. J Clin Microbiol 2004;42:3147-52
13. Wellinghausen N, Wirths B, Franz AR, et al. Algorithm for the identification of bacterial pathogens in positive blood cultures by real-time LightCycler polymerase chain reaction (PCR) with sequence-specific probes. Diagn Microbiol Infect Dis 2004;48:229-41
14. Mancini N, Carletti S, Ghidoli N, et al. The era of molecular and other non-cultured-based methods in diagnosis of sepsis. Clin Microbiol Rev 2010;23:235-51
15. Hansen WL, Beuving J, Bruggeman CA, Wolffs PF. Molecular probes for diagnosis of clinically relevant bacterial infections in blood cultures. J Clin Microbiol 2010;48:4432-8
16. Wellinghausen N, Nockler K, Sigge A, et al. Rapid detection of Brucella spp. In blood cultures by fluorescencein in situ hybridization. J Clin Microbiol 2006;44:1828-30
17. Pellestor F, Paulasova P, Hamamah S. Peptide nucleic acids (PNAs) as diagnostic devices for genetic and cytogenetic analysis. Curr Pharm Des 2008;14:2439-44
18. Oliveira K, Procop GW, Wilson D, et al. Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes. J Clin Microbiol 2002;40:247-51
19. Rigby S, Procop GW, Haase G, et al. Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J Clin Microbiol 2002;40:2182-6
20. Forrest GN, Mankes K, Jabra-Rizk MA, et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 2006;44:3381-3
21. Forrest GN, Roghmann MC, Toombs LS, et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 2008;52:3558-63
22. Marvin LF, Roberts MA, Fay LB. Matrix-assisted laserdesorption/ionization time-of-flight mass spectrometry in clinical chemistry. Clin Chim Acta 2003;337:11-21
23. van Baar BL. Characterisation of bacteria by matrix-assisted laserdesorption/ ionisation and electrospray mass spectrometry. FEMS Microbiol Rev 2000;24:193-219
24. Bernardo K, Fleer S, Pakulat N, et al. Identification of Staphylococcus aureus exotoxins by combined sodiumdodecyl sulfate gel electrophoresis and matrix-assisted laser desorption/ ionization-time of flight mass spectrometry. Proteomics 2002;2:740-6
25. Wolk DM, Blyn LB, Hall TA, et al. Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/electrospray ionization-mass spectrometry and correlation with phenotype. J Clin Microbiol 2009;47:3129-37
26. Cherkaoui A, Hibbs J, Emonet S, et al. Comparison of two matrix-assisted laser desorptionionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol 2010;48:1169-75
27. Ilina EN, Borovskaya AD, Malakhova MM, et al. Direct bacterial profiling by matrixassisted laser desorption-ionization time-of-flight mass spectrometry for identification of pathogenic Neisseria. J Mol Diagn 2009;11:75-86
28. Mellmann A, Bimet F, Bizet C, et al. High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol 2009;47:3732-4
29. Mellmann A, Cloud J, Maier T, et al. Evaluation of matrix-assisted laser desorption ionization-time-of-flight massspectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol 2008;46:1946-54
30. Stevenson LG, Drake SK, Murray PR. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010;48:444-7
31. von Wintzingerode F, Bocker S, Schlotelburg C, et al. Base specific fragmentation of amplified 16S rRNA genes analyzed by mass spectrometry: a tool for rapid bacterial identification. Proc Natl Acad Sci 2002;99:7039-44
32. Kaleta EJ, Clark AE, Johnson RD, et al. Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles. J Clin Microbiol 2011;49:345-53
33. Ecker DJ, Sampath R, Blyn LB, et al. Rapid identification and strain-typing of respiratory pathogens for epidemic surveillance. Proc Natl Acad Sci 2005;102:8012-17
34. Mayr BM, Kobold U, Moczko M, et al. Identification of bacteria by polymerase chain reaction followed by liquid chromatography-mass spectrometry. Anal Chem 2005;77:4563-70
35. Lisboa T, Waterer G, Rello J. We should be measuring genomic bacterial load and virulence factors. Crit Care Med 2010;38:656-62
36. Breitkopf C, Hammel D, Scheld HH, et al. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation 2005;111:1415-21
37. Domann E, Hong G, Imirzaglioglu C, et al. Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients. J Clin Microbiol 2003;41:5500-10
38. Gasanov U, Hughes D, Hansbro PM. Methods for the isolation and identification of Listeria spp. and Listeria monocytogenes: a review. FEMS Microbiol Rev 2005;29:851-75
39. Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents 2007;30S:S7-15
40. Schabereiter-Gurtner C, Nehr M, Apfalter P, et al. Evaluation of a protocol for molecular broad-range diagnosis of culture-negative bacterial infections in clinical routine diagnosis. J Appl Microbiol 2008;104:1228-37
41. El-Mahallawy HA, Shaker HH, Helmy HA, et al. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk pediatric cancer patients. Med Mycol 2006;44:733-9
42. Cuenca-Estrella M, Meije Y, Diaz-Pedroche C, et al. Value of serial quantification of fungal DNA by real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia. J Clin Microbiol 2009;47:379-84.
43. Klingspor L, Loeffler J. Aspergillus PCR formidable challenges and progress. Med Mycol 2009;47(Suppl1):S241-7
44. Lehmann LE, Hunfeld KP, Emrich T, et al. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008;197:313-24
45. Palka-Santini M, Putzfeld S, Cleven BE, et al. Rapid identification, virulence analysis and resistance profiling of Staphylococcus aureus by gene segment-based DNA microarrays: application to blood culture post-processing. J Microbiol Methods 2007;68:468-77
46. Cleven BE, Palka-Santini M, Gielen J, et al. Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray. J Clin Microbiol 2006;44:2389-97
47. Shang S, Chen G, Wu Y, et al. Rapid diagnosis of bacterial sepsis with PCR amplification and microarray hybridization in 16SrRNA gene. Pediatr Res 2005;58:143-8
48. Esparcia O, Montemayora M, Ginovartc G, et al. Diagnostic accuracy of a 16S ribosomal DNA gene-based molecular technique (RT-PCR, microarray, and sequencing) for bacterial meningitis, early-onset neonatal sepsis, and spontaneous bacterial peritonitis. Diagn Microbiol Infect Dis 2011;69:153-60
49. Louie RF, Tang Z, Albertson TE, et al. Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 2008;36:1487-92
50. Mancini N, Clerici D, Diotti R, et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 2008;57:601-4
51. Casalta JP, Gouriet F, Roux V, et al. Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis. Eur J Clin Microbiol Infect Dis 2009;28:569-73
52. Dierkes C, Ehrenstein B, Siebig S, et al. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009;9:126
53. Lehmann LE, Alvarez J, Hunfeld KP, et al. Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med 2009;37:3085-90
54. Varani S, Stanzani M, Paolucci M, et al. Diagnosis of bloodstream infections in immunocompromised patients by realtime PCR. J Infect 2009;58:346-51
55. von Lilienfeld-Toal M, Lehmann LE, Raadts AD, et al. Utility of commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 2009;47:2405-10
56. Wallet F, Nseir S, Baumann L, et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect 2010;16:774-9
57. Westh H, Lisby G, Breysse F, et al. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 2009;15:544-51
58. Bloos F, Hinder F, Becker K, et al. A multicenter trial to compare blood culture with polymerase chain reaction in severe sepsis. Intensive Care Med 2010;36:241-7
59. Tsalik EL, Jones D, Nicholson B, et al. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol 2010;48:26-33
60. Bravo D, Blanquer J, Tormo M, et al. Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients. Int J Infect Dis 2011;15:326-31
61. Muhl H, Kochem AJ, Disque C, Sakka SG. Activity and DNA contamination of commercial polymerase chain reaction reagents for the universal 16S rDNA real-time polymerase chain reaction detection of bacterial pathogens in blood. Diagn Microbiol Infect Dis 2010;66:41-9
62. Reinhart K, Hartog CS. Biomarkers as a guide for antimicrobial therapy. Int J Antimicrob Agents 2010;36(Suppl):S17-21
63. Wunder C, Eichelbronner O, Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 2004;53:158-63
64. Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002;28:1351-6
65. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-17
66. Dimopoulou I, Pelekanou A, Mavrou I, et al. Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: Correlation with monocyte gene expression. J Crit Care 2011; [Epub ahead of print]
67. White M, Mahon V, Grealy R, et al. Post-operative infection and sepsis in humans is associated with deficient gene expression of gammac cytokines and their apoptosis mediators. Crit Care 2011;15:R158
68. Giamarellos-Bourboulis EJ, van de Veerdonk Mouktaroudi M, et al. Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia. Crit Care 2011;15:R27
69. McCall CE, Yoza BK. Gene silencing in severe systemic inflammation. Am J Respir Crit Care Med 2007;175:763-7
70. Tang BM, Huang SJ, McLean AS. Genome-wide transcription profiling of human sepsis: a systemic review. Crit Care 2010;14:R237
71. Hinrichs C, Kotsch K, Buchwald S, et al. Perioperative gene expression analysis for prediction of postoperative sepsis. Clin Chem 2010;56:613-22
72. Johnson SB, Lissauer M, Bochicchio GV, et al. Gene expression profiles between sterile SIRS and early sepsis. Ann Surg 2007;245:611-21
73. Tang BMP, McLean AS, Dawes IW, et al. Gene profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009;37:882-8
74. Talwar S, Munson PJ, Barb J, et al. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics 2006;25:203-15
75. Wong HR, Cvijanovich N, Allen GL, et al. Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis and septic shock spectrum. Crit Care Med 2009;37:1558-66
76. Wong HR, Freishtat RJ, Monaco M, et al. Leukocyte subset-derived genomewide expression profiles in pediatric septic shock. Pediatr Crit Care Med 2010;11:249-55
77. Wong HR, Wheeler DS, Tegtmeyer K, et al. Toward a clinically feasible gene expression-based sub-classification strategy for septic shock: proof of concept. Crti Care Med 2010;38:1955-61
78. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008;36:296-327